In a new article for ICT, Vicky Marriott, Helen Marshall, Hebing Wang and Samantha Hinsley from Phastar explore how advanced statistical methods are transforming clinical trials and helping generate more meaningful evidence for patients worldwide.
The article examines key developments shaping modern clinical research, including Bayesian and adaptive methodologies, innovative early-phase trial designs, and the growing role of real-world evidence (RWE). The authors explain how these approaches are making studies more efficient, flexible, and relevant while supporting robust regulatory decision-making and improving patient outcomes.
Alongside showcasing the real-world impact of statistics, from landmark breast cancer research to insights from dermatology studies, the article also highlights the importance of building a more inclusive profession. The authors discuss practical ways organizations can support diversity, champion women in statistics and data science, and encourage the next generation of talent to pursue careers in the field.